Ronald Martell

Ronald Martell is currently an advisor at Orca Bio, a position they have held since April 2021. Prior to that, they were the President and CEO of Nuvelution Pharmaceuticals from November 2019 to April 2021. Ronald has also served as the Executive Director of Havah Therapeutics from January 2017 to March 2022, and as the Director of Plus Therapeutics from December 2016 to November 2019. Ronald is also a co-founder of Encellin and Indapta Immuno Therapeutics, and the chairman of Cetya Pharmaceuticals, Colorado State University & Dana Farber Cancer Institute. Ronald has been an advisor at Keck School of Medicine of the University of Southern California since March 2013.

Ronald Martell attended The University of Akron for their undergraduate degree. Ronald then went on to earn their law degree from the same school.